Terence Novak
2014
In 2014, Terence Novak earned a total compensation of $1.8M as Chief Operating Officer at Pernix Therapeutics Holdings.
Compensation breakdown
| Bonus | $170,000 |
|---|---|
| Option Awards | $1,231,051 |
| Salary | $354,160 |
| Other | $8,766 |
| Total | $1,763,977 |
Novak received $1.2M in option awards, accounting for 70% of the total pay in 2014.
Novak also received $170K in bonus, $354.2K in salary and $8.8K in other compensation.
Rankings
In 2014, Terence Novak's compensation ranked 5,046th out of 13,032 executives tracked by ExecPay. In other words, Novak earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,046 out of 13,032 | 61st |
Division Manufacturing | 1,797 out of 4,965 | 64th |
Major group Chemicals And Allied Products | 592 out of 1,690 | 65th |
Industry group Drugs | 452 out of 1,369 | 67th |
Industry Pharmaceutical Preparations | 361 out of 1,042 | 65th |
Source: SEC filing on May 8, 2015.
Novak's colleagues
We found three more compensation records of executives who worked with Terence Novak at Pernix Therapeutics Holdings in 2014.